Search for: "MCNEIL v. WYETH"
Results 61 - 80
of 92
Sort by Relevance
|
Sort by Date
28 Jul 2010, 12:06 am
(EDTexweblog.com) (Docket Report) US: Post-Bilski: Federal Circuit to reconsider diagnostic testing and medical methods – Prometheus v Mayo, Classen v Biogen (IP Spotlight) (Patently-O) US: Federal Circuit review of patent term extensions – Ortho-McNeil v Lupin, Photocure v Kappos (Patently-O) USPTO provides clarification regarding treatment of PTA letters (Patent Docs) US: Pharmaceutical reverse payments and lower drug costs: An… [read post]
5 Jul 2010, 8:54 am
This holding does not otherwise affect the conclusion of the Court in Wyeth that plaintiffs may bring state claims even where the FDA approved the label.Lofton v. [read post]
22 Jun 2010, 9:45 pm
Kappos and Ortho-McNeil Pharmaceutical, Inc. v. [read post]
27 May 2010, 3:20 am
(Patent Docs) Levaquin (Levofloxacin) – US: When it comes to patent term extensions, an enantiomer is a different drug from racemate: Ortho-McNeil Pharma v. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Levaquin (Levofloxacin) - US: CAFC upholds patent term extensions in Levaquin and Metvixia cases: Ortho-McNeil and Daiichi Sankyo v. [read post]
10 May 2010, 11:26 am
In Wyeth v. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
29 Jan 2010, 6:15 am
Wyeth-Ayerst Labs., 385 F.3d 961, 965-66 (6th Cir. 2004). [read post]
12 Nov 2009, 9:17 am
Ortho-McNeil Pharmaceutical, Inc., 463 F. [read post]
17 Sep 2009, 4:30 am
McNeil Laboratories, Inc., 807 F.2d 464 (5th Cir. 1987). [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously… [read post]
10 Jun 2009, 10:00 pm
Ortho-McNeil Pharmaceutical, 2007 WL 121149, at *4 (S.D. [read post]
20 May 2009, 5:18 am
’ (Patent Docs) Atripla/Truvada (Efavirenz, Emtricitabine, Tenofovir) – US: Gilead Sciences files second patent infringement lawsuit against Teva Pharmaceuticals over Emtricitabine, a component of Truvada and Atripla (SmartBrief) (The IP Factor) (GenericsWeb) Champix (Varenicline) – India: Pfizer responds to Dr Reddy’s post-grant opposition to Champix filed at Mumbai Patent Office (GenericsWeb) (Spicy IP) Corpril (Ramipril) – Hungary: Metropolitan… [read post]
5 May 2009, 5:00 am
McNeil Pharm., No. 3:98cv105, 2000 U.S. [read post]
20 Mar 2009, 2:05 am
A linchpin of the preemption analysis in Wyeth v. [read post]
9 Mar 2009, 7:06 am
The Court, following up on its ruling last week in Wyeth v. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
